v3.26.1
Organization, Liquidity and Basis of Presentation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
May 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Date of incorporation   Feb. 14, 2019    
Retained earnings accumulated deficit   $ (379,070)   $ (330,549)
Cash flow from used in operating activities   (41,305) $ (42,824)  
Cash, cash equivalents and investments   349,400    
Proceeds from issuance public offering and prefunded warrants $ 300,000      
Payment of costs related to public offering and pre-funded warrants 17,300      
Sale of stock net consideration received on the transaction $ 282,700      
Cumulative gross proceeds from convertible notes derivative instruments and redeemable convertible preferred stock   $ 741,900    
Pre-funded Warrants [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Issuance of warrants in lieu of common stock 2,170,138      
Purchase price of warrants $ 11.5199      
Exercise price of warrants $ 0.0001      
Public Equity Offering [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Issued and sale of common stock 23,871,526      
Sale of stock issue price per share $ 11.52